ACM
SCMP

Argent Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Argent Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-90,400
Closed -$1.07M – 222
2017
Q3 		$1.07M Buy
+90,400
New +$1.01M 0.04% 136

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Argent Capital Management's SCMP Position: Q4 2017 in Review

Argent Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2017, closing a stake of 90,400 shares — an estimated $1.07M sold.

Argent Capital Management first reported a position in SCMP in Q3 2017 and held it in 1 quarter. The position peaked at $1.07M in Q3 2017. 188 funds tracked by Wall St. Rank hold SCMP as of Q4 2017.

  • Argent Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Argent Capital Management sold 90,400 Sucampo Pharmaceuticals, Inc. shares in Q4 2017, an estimated $1.07M.
  • Argent Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2017 and held it in 1 quarter.
  • Argent Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $1.07M in Q3 2017.
  • 188 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2017.

Based on Argent Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.